z-logo
open-access-imgOpen Access
Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica
Author(s) -
Frank Hoffmann,
Andrea Kraft,
Franz Heigl,
E. Mauch,
Jürgen Koehler,
Lutz Harms,
Tania Kümpfel,
Wolfgang Köhler,
Sven Ehrlich,
Antonios Bayas,
Julia WeinmannMenke,
Carolin Beuker,
KarlHeinz Henn,
Ilya Ayzenberg,
Gisa Ellrichmann,
Kerstin Hellwig,
Reinhard Klingel,
Cordula Fassbender,
Harald Fritz,
Torsten Slowinski,
H. Weihprecht,
Marcus Brand,
Thomas Stiegler,
Jan Galle,
Sebastian Schimrigk
Publication year - 2018
Publication title -
therapeutic advances in neurological disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.684
H-Index - 50
eISSN - 1756-2864
pISSN - 1756-2856
DOI - 10.1177/1756286418774973
Subject(s) - medicine , neuromyelitis optica , multiple sclerosis , breastfeeding , immunoadsorption , pregnancy , pediatrics , intensive care medicine , immunology , antibody , biology , genetics
Tryptophan-IA was found to be effective and well tolerated in MS/NMOSD relapses, both as an escalation option after insufficient response to steroid pulse therapy and as first-line relapse treatment during pregnancy and breastfeeding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom